Haemonetics Corporation
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Regulation FD disclosureAug 18 →Insiders1 insider bought $98,784 in 1 open-market buy. No sales.→HoldersBlackRock 13.0%Neuberger Berman 9.2%Vanguard Portfolio 5.6%→PeersClosest companies: MDT, IART, ANGO→
From the filings
Figures
- Revenue
- $1.35Blast 12 months
- Net income
- −$923,692last 12 months
- Operating cash flow
- $328.1Mlast 12 months
- Cash and equivalents
- $223.4Mat the last balance sheet
- Total debt
- $1.17Bat the last balance sheet
- Shares outstanding
- 45.5M shareson issue